Colorectal cancer surveillance with chromoendoscopy in inflammatory bowel disease: results from a real-life experience.

BACKGROUND: Patients with inflammatory bowel disease are at increased risk for colorectal cancer. The aim of this study was to know the prevalence of dysplasia and colorectal cancer with chromoendoscopy, to describe the characteristics and the management of the detected lesions and to identify possible risk factors of dysplasia in clinical practice. METHODS: Observational, retrospective study of all chromoendoscopies performed between January 2016 and May 2019 in patients with left-sided/extensive ulcerative colitis or Crohn's disease involving more than one-third of the colon. Information about all the polyps' characteristics and the treatments received was collected. RESULTS: A total of 186 chromoendoscopies on 160 patients were reviewed; 57% were men; 54% had ulcerative colitis. The dysplasia detection rate was 24% and 212 lesions were detected: rectum (36%) and left colon (30%). Flat polyps were detected in 57% patients. In total, 123 (62%) lesions were non-neoplastic and 74 (38%) were neoplastic. Among these, 69 (93%) were low grade dysplasia and five (7%) were high grade dysplasia, all of them located in rectum. Two patients (1%) required surgery. During follow-up, no patient developed colorectal cancer. Age over 60 years, flat lesions, polyp >5 mm and right colon localization were found to be risk factors for dysplasia. CONCLUSIONS: This study reports a high dysplasia detection rate (24%) via targeted chromoendoscopic biopsies. In most cases, lesions were successfully removed by endoscopic resection. Our results underline the importance of colorectal cancer surveillance in inflammatory bowel disease patients.

Educación para pacientes / Education for patients

Resumen: Una parte fundamental en todo proyecto de mejora continua es la apropiada información y educación para el paciente y su familia. Las expectativas de una intervención quirúrgica, del curso perioperatorio y de la experiencia del dolor, puede ser distinta, de acuerdo con las creencias y el estado previo de ansiedad provocado por la incertidumbre y el miedo a lo desconocido, lo cual puede provocar un manejo del dolor menos efectivo. Esta variabilidad en la respuesta frente al evento quirúrgico puede ser optimizada en el momento que se proporciona la información de todo el proceso de manera objetiva. Dentro del proyecto de Investigación de PAIN OUT para la optimización del manejo del dolor perioperatorio, coordinado por el departamento de Anestesiología en el INCMNSZ, se planteó la posibilidad de implementar estrategias de educación para la población general. El Departamento de Educación para la Salud del INCMNSZ, tiene como objetivo apoyar y asesorar a las distintas áreas del hospital en materia de educación y promoción de la salud, que contribuyan a generar una cultura de prevención y autocuidado en el paciente y su familia. En un esfuerzo conjunto de estos dos departamentos se planteó la posibilidad de generar material audiovisual que cumpliera con el objetivo primordial de educar en el contexto perioperatorio. Se crearon tres audiovisuales con el apoyo de diseñadores gráficos del Instituto Tecnológico y de Estudios Superiores de Monterrey, Campus Ciudad de México. El primero incluye información acerca del proceso anestésico; el segundo habla del dolor postoperatorio, su evaluación por parte del paciente y las alternativas de manejo durante la hospitalización y el egreso; mientras que el tercero tiene información sobre los mitos y realidades del uso de opioides como parte de una estrategia analgésica. Este material tiene el objetivo de ser difundido entre la población general, a través del sitio web de la Red Mexicana PAIN OUT para la optimización del manejo del dolor perioperatorio http://www.painoutmexico.com y del sitio webhttps://www.epsnutricion.com.mx/quienes.php

Abstract: A fundamental part of any continuous improvement project is the appropriate information and education for the patient and his family. The expectations of a surgical intervention, of the perioperative course and of the experience of pain, can be different, according to the beliefs and previous state of anxiety caused by uncertainty and fear of the unknown, which can favor a less effective management of pain. This variability in the response to the surgical event can be optimized if the information of the entire process is provided objectively beforehand. The PAIN OUT Research project for the optimization of perioperative pain management, coordinated by the Department of Anesthesiology at INCMNSZ, provides the possibility of implementing education strategies for the general population was raised. The Department of Health Education of INCMNSZ aims to support and advise the different areas of the hospital in terms of education and health promotion, which contribute to generate a culture of prevention and self-care in the patient and his family. In a joint effort of these two departments, the possibility of generating audiovisual material that met the primary objective of educating in the perioperative context was done. Three audiovisuals were created with the support of graphic designers from the Tecnológico y Estudios Superiores de Monterrey, Mexico City Campus. The first includes information about the anesthetic process, the second includes information about postoperative pain, its evaluation by the patient and management alternatives during hospitalization and discharge, and the third includes information about the myths and realities of the use of opioids as part of an analgesic strategy. This material is intended to be disseminated to the general population, through the website of the Mexican PAIN OUT Network for the optimization of perioperative pain management http://www.painoutmexico.com and the website https://www.epsnutricion.com.mx/quienes.php

Safety and Oncological Outcomes of Bevacizumab Therapy in Patients With Advanced Colorectal Cancer and Self-expandable Metal Stents.

BACKGROUND: Malignant bowel obstruction can occur in 18% of cases. Self-expandable metal stents (SEMS) can be an alternative to surgery. Bevacizumab (BV) has been associated with bowel perforation, but data on the safety of SEMS for occlusive colon cancer during BV-containing regimens are lacking. MATERIAL AND METHODS: This is a retrospective analysis of 78 patients with malignant bowel obstruction who underwent placement of SEMS as a palliative intent for stage IV disease. Chemotherapy and BV-containing regimens, stent-related complications, and outcomes were recorded. RESULTS: Overall, major stent-related complications were observed in 27 (35%) patients: Re-obstruction occurred in 14 (52%) patients, and there were 7 (26%) perforations, 4 (15%) minor bleeding, and 2 (7%) migrations. Sixteen patients received BV; 2 (12.5%) had a perforation. No differences were observed between chemotherapy alone and BV in overall complications. Univariate analysis did not show that BV was more likely to develop perforations, although the incidence was higher in this subset of patients. Kaplan-Meier analysis showed a significant association with longer overall survival for patients treated with systemic therapy (27 vs. 11 months; P ≤ .00001). Also, there is a significant benefit of BV compared with chemotherapy alone (43 vs. 39 months; P = .02). CONCLUSION: Placement of SEMS is effective and relatively safe but with an overall complication rate of 35% in the metastatic setting. The major early risk is perforation, which can increase up to 12% during BV treatment. In patients with obstructing advanced colorectal cancer that would benefit from SEMS, we should consider the risks associated with systemic therapies, taking into account the improvement in survival observed with BV.

Diseño del instrumento de ayuda para la toma de decisiones: “alternativas de tratamiento para el cáncer de mama: ¿qué opción prefiero? / Design a decision-making aid: “alternative treatment for breast cancer: What option do you prefer?

Objetivo: Diseñar un Instrumento de Ayuda para la Toma de Decisiones (IATD) en el Proceso Asistencial Integrado ‘Cáncer de mama’ del Sistema Sanitario Público de Andalucía (SSPA) para el abordaje terapéutico de esta enfermedad en estadio inicial. Método: El diseño del IATD se realizó en cuatro fases: 1) Explorar la receptividad de las usuarias y los profesionales del SSPA sobre la incorporación de IATD en el proceso “Cáncer de mama”. 2). Seleccionar un IATD entre las experiencias internacionales.; 3) Adaptar transculturalmente del IATD seleccionado al entorno del SSPA. 4) Validar el IATD en el SSPA. Resultado: El IATD “Alternativas de tratamiento para el cáncer de mama: ¿Qué opción prefiero?” diseñado para el SSPA incluye contenidos innovadores frente a otras experiencias revisadas. Los resultados de la validación del IATD han mostrado que su diseño es atractivo para la paciente, su extensión y lenguaje idóneos, y la información clínica que contiene es de calidad. El Instrumento resuelve sus dudas (95%) y resume la información esencial para tomar la decisión (90%). El IATD ofrece información relevante que prepara a la paciente para la toma de decisiones (ausencia de conflicto decisional: 85,31), facilita la labor en consulta y la comunicación médico-paciente. Conclusiones: Pacientes y profesionales coinciden en recomendar la utilización del IATD y fomentar la participación en la toma de decisiones aunque reconocen que el factor tiempo es el principal obstáculo para incorporar su uso en el SSPA. (AU)

Purpose: To design a Decision-making Aid within the ‘Breast cancer’ healthcare process modelling of the Andalusian Public Health System (SSPA) for the therapeutic approach of early-stage disease. Methods: The Decision Aid design was conducted in four phases: 1) Explore the receptiveness of users and professionals in the mainstream of the SSPA Decision Aid “Breast Cancer” process. 2) Select a Decision Aid from international experiences. 3) Transcultural adaptation of above selected Decision Aid. 4) Decision Aid Validation in the SSPA. Results: The Decision Aid “Alternative treatment for breast cancer: What option do I prefer?” designed for the SSPA includes innovative contents compared to other reviewed experiences. The results of the validation of Decision Aid have shown that the design is attractive for the patient, ideal size and suitable language, and that the clinical information it contains is of quality. The Decision Aid an- swers your questions (95%) and summarizes the essential information to make the decision (90%). The Decision Aid offers relevant information that help the patient in the decision making process (lack of decisional conflict: 85.31), facilitates the work in the practice and doctor-patient communication. Results: The Decision Aid “Alternative treatment for breast cancer: What option do I prefer?” designed for the SSPA includes innovative contents compared to other reviewed experiences. The results of the validation of Decision Aid have shown that the design is attractive for the patient, ideal size and suitable language, and that the clinical information it contains is of quality. The Decision Aid an- swers your questions (95%) and summarizes the essential information to make the decision (90%). The Decision Aid offers relevant information that help the patient in the decision making process (lack of decisional conflict: 85.31), facilitates the work in the practice and doctor-patient communication. Conclusion: Patients and professionals agree to recommend the use of Decision Aid and to encourage participation in decision making while recognizing that the time factor is the main obstacle to incorporate its use in the SSPA (AU)